Track topics on Twitter Track topics that are important to you
Helsinn Group has entered into an exclusive distribution and license agreement with BIAL for the exclusive…
PORTO, PORTUGAL, 12 June 2015 BIAL is presenting 11 research posters at the 19th International Congress of Parkinson's Disease and Movement Disorders (June 1415, San Diego, CA). These evaluate the sa...
LUGANO, Switzerland and PORTO, Portugal, September 8, 2015 /PRNewswire/ -- Anamorelin is a novel ghrelin receptor agonist in development for the treatment of cancer anorexia-cachexia syndrome ...
Only exclusively once-daily, non-extended release antiepileptic drug (AED) now FDA-approved as both monotherapy and adjunctive therapy for partial-onset seizures ...
Company has contributed clinical advances and new treatment options, led advocacy and educational initiatives to address serious medical conditions Sunovion Phar...
Recently added to the BioPortfolio report store, Chronic Heart Failure - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-05-28. This 142-page report is available...
Recently added to the BioPortfolio report store, Pulmonary Hypertension - Global Market Research 2015-2019 is a new report from Technavio published on 2015-09-29. This 65-page report is available in ...
PUNE, India, October 9, 2015 /PRNewswire/ -- According to the Pulmonary Hypertension - Global Market Research 2015-2019 report, hypertension treatment is shifting toward the use of combination therap...